Malik_2012_Clin.Pharmacol.Ther_92_696

Reference

Title : Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study - Malik_2012_Clin.Pharmacol.Ther_92_696
Author(s) : Malik M , van Gelderen EM , Lee JH , Kowalski DL , Yen M , Goldwater R , Mujais SK , Schaddelee MP , de Koning P , Kaibara A , Moy SS , Keirns JJ
Ref : Clinical Pharmacology & Therapeutics , 92 :696 , 2012
Abstract : Malik_2012_Clin.Pharmacol.Ther_92_696
ESTHER : Malik_2012_Clin.Pharmacol.Ther_92_696
PubMedSearch : Malik_2012_Clin.Pharmacol.Ther_92_696
PubMedID: 23149929

Related information

Citations formats

Malik M, van Gelderen EM, Lee JH, Kowalski DL, Yen M, Goldwater R, Mujais SK, Schaddelee MP, de Koning P, Kaibara A, Moy SS, Keirns JJ (2012)
Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study
Clinical Pharmacology & Therapeutics 92 :696

Malik M, van Gelderen EM, Lee JH, Kowalski DL, Yen M, Goldwater R, Mujais SK, Schaddelee MP, de Koning P, Kaibara A, Moy SS, Keirns JJ (2012)
Clinical Pharmacology & Therapeutics 92 :696